IMV Valor da empresa
Qual é o Valor da empresa de IMV?
O Valor da empresa de IMV, Inc. é $25.88M
Qual é a definição de Valor da empresa?
O valor da empresa é uma medida do valor total de mercado de uma empresa. É calculado como capitalização de mercado com dívida, participação minoritária e ações preferenciais menos o total de caixa e equivalentes de caixa.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valor da empresa de empresas na Setor Health Care em TSX em comparação com IMV
O que IMV faz?
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Empresas com valor da empresa semelhantes a IMV
- Volatus Aerospace Corp tem Valor da empresa de $25.84M
- Technologies tem Valor da empresa de $25.84M
- Bigblu Broadband plc tem Valor da empresa de $25.85M
- Fremont Petroleum tem Valor da empresa de $25.87M
- HighGold Mining tem Valor da empresa de $25.87M
- Asia Commercial tem Valor da empresa de $25.87M
- IMV tem Valor da empresa de $25.88M
- Bionomics tem Valor da empresa de $25.89M
- DMG Blockchain Solutions tem Valor da empresa de $25.89M
- Mallinckrodt plc tem Valor da empresa de $25.90M
- Alien Metals tem Valor da empresa de $25.91M
- Vst Building Techs Ag tem Valor da empresa de $25.92M
- Invitrocue tem Valor da empresa de $25.93M